Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Planning For Exchanges: Pharma Hopes For “Broad Enrollment,” But Timeline Causes Concern

Executive Summary

For pharmaceutical companies, the barometer for measuring success of the health plan exchanges created under the health care reform law will be how well they encourage broad enrollment.

You may also be interested in...



CMS Budget Plan: $1 Bil. Increase For Administrative Activities Is New, But Drug Policy Proposals Are Old

CMS budget plan reprises Medicare drug rebates for dual eligibles, eliminating brand/generic patent settlements and other unsuccessful Rx proposals.

Medicare ACO Plan Could Improve Rx Compliance But Lacks Guidance On Drug Management Policies

Medicare-sanctioned accountable care organizations could significantly improve drug adherence among beneficiaries as a way to prevent more costly medical interventions later, under a widely-anticipated CMS proposal.

Drug Coverage In Exchange Plans Should Be On Par With Other "Essential Benefits," PhRMA Tells IoM

PhRMA was among a number of stakeholders presenting comments Jan. 14 to the committee on criteria and methods for determining and updating what qualifies as "essential health benefits" in the exchange plans.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053332

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel